Reductive effect of ursodeoxycholic acid on bilirubin levels in neonates on phototherapy

References

• Tikmani SS, Warraich HJ, Abbasi F, Rizv A, Darmstadt GL, Zaidi AKM. Incidence of neonatal hyperbilirubinemia: a population-based prospective study in Pakistan. Trop Med Int Health. 2010;15:502–507. doi:10.1111/j.1365-3156.2010.02584.x20412075
   PubMed Web of Science ®Google Scholar
• Shapiro SM. Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). J Perinatol. 2005;25:54–59. doi:10.1038/sj.jp.721115715578034
   PubMedGoogle Scholar
• Bratlid D, Nakstad B, Hansen TWR. National guidelines for treatment of jaundice in the newborn. Acta Paediatr. 2011;100:499. doi:10.1111/j.1651-2227.2010.02104.x21114525
   PubMed Web of Science ®Google Scholar
• Rennie JM, Sehgal A, De A, Kendall GS, Cole TJ. Range of UK practice regarding thresholds for phototherapy and exchange transfusion in neonatal hyperbilirubinaemia. Arch Dis Child Fetal Neonatal Ed. 2009;94:F323–7. doi:10.1136/adc.2008.14768619000996
   PubMed Web of Science ®Google Scholar
• Snook J. Is home phototherapy in the term neonate with physiological jaundice a feasible practice? A systematic literature review. J Neonatal Nurs. 2016; Accessed December 2nd 2016. doi:10.1016/j.jnn.2016.08.001
   Google Scholar
• Eggert LD, Pollary RA, Folland DS, Jung AL. Home phototherapy treatment of neonatal jaundice. Pediatrics. 1985;76:579–584.4047802
   PubMed Web of Science ®Google Scholar
• Murki S, Dutta S, Narang A, Sarkar U, Garewal G. A randomized, triple-blind, placebo-controlled trial of prophylactic oral phenobarbital to reduce the need for phototherapy in G6PD-deficient neonates. J Perinatol. 2005;25:325–330. doi:10.1038/sj.jp.721125815716985
   PubMedGoogle Scholar
• Kappas A, Drummond GS, Valaes T. A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns. Pediatrics. 2001;108:25–30. doi:10.1542/peds.108.6.136711433050
   PubMed Web of Science ®Google Scholar
• Bhatia V, Bavdekar A, Matthal J, Waikar Y, Sibal A. Management of neonatal cholestasis: consensus statement of the pediatric gastroenterology chapter of Indian Academy of Pediatrics. Indian Pediatr. 2014;15:203–210. doi:10.1007/s13312-014-0375-2
   Web of Science ®Google Scholar
• Best C, Gourley GR. Management of neonatal cholestasis. Therapy. 2009;6:75–81. doi:10.2217/14750708.6.1.75
   Google Scholar
• Lirussi F, Okolicsanyi L. Cytoprotective with ursodeoxycholic acid: effect in chronic non-cholestatic and chronic cholestatic liver disease. Ital J Gastroenterol. 1992;24:31–35.1571577
   PubMedGoogle Scholar
• Hillaire S, Ballet F, Franco D, Setchell KD, Poupon R. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture. Hepatology. 1995;22:82–87. doi:10.1002/hep.18402201137601437
   PubMed Web of Science ®Google Scholar
• Cuperus FJC, Iemhoff AA, Verkade HJ. Combined treatment strategies for unconjugated hyperbilirubinemia in gunn rats. Pediatr Res. 2011;70:560–565. doi:10.1203/PDR.0b013e31822e63b321857383
   PubMed Web of Science ®Google Scholar
• Palmela I, Correla L, Silva R, et al. Hydrohilic bile acids protect human blood brain barrier endothelial cells from disruption by unconjugated bilirubin: an in vitro study. Front Neurosci. 2015;9:80. doi:10.3389/fnins.2015.0008025821432
   PubMed Web of Science ®Google Scholar
• Honar N, Ghashghaei Saadi E, Saki F, Pishva N, Shakibazad N, Hosseini Teshnizi S. Effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy. J. Pediatr Gastroenterol Nutr. 2016;62:97–100. doi:10.1097/MPG.000000000000087426020375
   PubMed Web of Science ®Google Scholar
• Hassan A, Babadoko AA, Ahmed AJ, Suleiman AM. The pattern of distribution of ABO blood groups in North Western Nigeria. Ann Niger Med. 2005;1:17–18.
   Google Scholar
• Jafari S, Khan KA, Bhatnagar S, Srivastava G, Nanda C, Chandra A. Role of ursodeoxycholic acid in neonates with indirect hyperbilirubinemia-an open labelled randomized control trial. Int J of Contemp Pediatr. 2018;5(2):432–435. doi:10.18203/2349-3291.ijcp20180530
   Google Scholar
• Yurdakok M. Phototherapy in the newborn: what’s new? J Pediatr Neonatal Individualized Med. 2015;4(2):e040255. doi:10.7363/040255
   Google Scholar
• Maisels MJ, McDonagh A. Phototherapy for neonatal jaundice. N Engl J Med. 2008;358(9):920–928. doi:10.1056/NEJMct070837618305267
   PubMed Web of Science ®Google Scholar
• Zonios G, Bykowski J, Kollias N. Skin melanin, hemoglobin and light scattering properties can be quantitatively assessed in vivo using diffuse reflectance spectroscopy. J Invest Derm. 2001;117(6):1452–1457. doi:10.1046/j.1523-1747.2001.01378.x11886508
   PubMed Web of Science ®Google Scholar
• British Pharmacopoeia. Available from: https://www.pharmacopoeia.com. Accessed March 9, 2018.
   Google Scholar
• American Academy of Pediatrics. Subcommittee on hyperbilirubinemia. Clinical practice guideline: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316. doi:10.1542/peds.114.1.29715231951
   PubMed Web of Science ®Google Scholar
• Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF. Hyperbilirubinemia in the newborn infant > or =35 weeks’ gestation: an update with clarifications. Pediatrics. 2009;124:1193–1198. doi:10.1542/peds.2009-032919786452
   PubMed Web of Science ®Google Scholar
• Brown AK, Kim BM, Paul Y, Wu K, Dolores AB. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics. 1985;75:393–400.3881731
   PubMed Web of Science ®Google Scholar
• Oyedeji GA. Socioeconomic and cultural background of hospitalized children in Ilesa. Nig J Paediatr. 1995;12:111–117.
   Google Scholar
• Montquin JM. Classification and heterogeneity of preterm births. BJOG. 2003;110(20):30–33. doi:10.1046/j.1471-0528.2003.00021.x12763108
   PubMed Web of Science ®Google Scholar
• Chlesa C, Panero A, Osborn JF, Simoneti AF, Pacifico SL. Diagnosis of neonatal sepsis: a clinical and laboratory challenges. Clin Chem. 2004;50(2). doi:10.1373/clinchem2003.025171
   Web of Science ®Google Scholar
• Maldonado SR, Tellez NCG, Yescas-Buendia G, Rios ERR. Effectiveness of ursodeoxycholic acid vs phenobarbital for the treatment of neonatal cholestasis: a cross-randomized clinical trial. Bol Med Hosp Infant Mex. 2010;67:418–424.
   Google Scholar